Validation of a Cognitive Remediation Program for Bipolar Disorders
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Bipolar Disorder
- Sponsor
- Centre hospitalier de Ville-Evrard, France
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Change from baseline Perceptual Reasoning Index at 3 months
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
This study evaluates the effect of a new cognitive remediation program designed for patients suffering from a bipolar disorder, on cognitive functions, psychosocial functioning and neural processes. In this double-blind (patient, outcomes assessor) controlled randomized trial the investigators compare patients receiving the ECo program for bipolar disorders, to patients benefiting from the broadly used cognitive remediation program CRT and to patients receiving supportive psychotherapy. Patients are treated for 3 months and monitored for 9 months.
Investigators
Clémence ISAAC
Psychologist
Centre hospitalier de Ville-Evrard, France
Eligibility Criteria
Inclusion Criteria
- •Type I or type II Bipolar Disorder diagnosis, according to DSM-IV-TR criteria
- •No Manic or Major Depressive episode during the last three months
- •No or few residual depressive symptoms (HDRS-17 ≤ 12)
- •No or few residual manic symptoms (YMRS ≤ 8)
- •Stable dose of medication for the last two months
- •Cognitive complaint expressed by the patient and impairment observed by the patient's regular psychiatrist
- •Informed consent form read, initialed and signed
- •Patient registered on the social welfare system
Exclusion Criteria
- •Other diagnosis than Bipolar Disorder on axis I of the DSM-IV-TR
- •Rapid Cycling Bipolar Disorder diagnosis
- •Addiction or substance abuse (except tobacco) during the twelve last months
- •Physical or neurological disorder that can lead to cognitive impairment
- •Engagement in a research protocol either currently or over the last month
- •Neuropsychological assessment or Rorschach Inkblot Test evaluation during the last six months
- •Ineligibility for Magnetic Resonance Imaging \[MRI\] (e.g. claustrophobia, metallic implants, pace-maker, etc.)
Outcomes
Primary Outcomes
Change from baseline Perceptual Reasoning Index at 3 months
Time Frame: baseline and 3 months
Composite score of the Wechsler Adult Intelligence Scale - fourth edition
Change from 3-months Perceptual Reasoning Index at 9 months
Time Frame: 3 months and 9 months
Composite score of the Wechsler Adult Intelligence Scale - fourth edition
Secondary Outcomes
- Emotion Hexagon(baseline, 3 months and 9 months)
- Key Search Test(baseline, 3 months and 9 months)
- Hamilton Depression Rating Scale(15 days before baseline, 3 months and 9 months)
- Young Mania Rating Scale(15 days before baseline, 3 months and 9 months)
- Functional Repercussions Scale(baseline, 3 months and 9 months)
- Social Desirability Scale(baseline, 3 months and 9 months)
- Social Relationships Scale(baseline, 3 months and 9 months)
- Self-Appraisal of Illness Questionnaire(baseline, 3 months and 9 months)
- Rorschach Inkblot Test(baseline, 3 months and 9 months)
- Change from baseline Event-Related Potentials [ERP] P300 at 3 months during an Oddball task(baseline and 3 months)
- Change from baseline Event-Related Potentials [ERP] N2/P3 complex at 3 months during an emotional Stroop task(baseline and 3 months)
- Change from baseline serum Brain-Derived Neurotrophic Factor [BDNF] level (ng/mL) at 3 months(baseline and 3 months)
- Change from baseline functional Magnetic Resonance Imaging frontal activation at 3 months during an emotion recognition task(baseline and 3 months)
- Processing Speed Index(baseline, 3 months and 9 months)
- Working Memory Index(baseline, 3 months and 9 months)
- Cardebat's Verbal Fluencies(baseline, 3 months and 9 months)
- Rey Auditory Verbal Learning Test(baseline, 3 months and 9 months)
- Stroop Color Word Test(baseline, 3 months and 9 months)